Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Angiotensin-Converting Enzyme Inhibitors"" wg kryterium: Temat


Tytuł :
Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
Autorzy :
Lam KW; Department of Radiology, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Chow KW; Department of Radiology, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Vo J; Department of Radiology, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Hou W; Department of Radiology, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Li H; Department of Radiology, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Richman PS; Department of Medicine, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Mallipattu SK; Department of Medicine, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Skopicki HA; Department of Medicine, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Singer AJ; Department of Emergency Medicine, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Duong TQ; Department of Radiology, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Sep 14; Vol. 222 (8), pp. 1256-1264.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J. Infect. Dis. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists/*therapeutic use
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Coronavirus Infections/*mortality
Hypertension/*drug therapy
Hypertension/*virology
Pneumonia, Viral/*mortality
Acute Kidney Injury/chemically induced ; Aged ; Aged, 80 and over ; Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Betacoronavirus/isolation & purification ; Coronavirus Infections/drug therapy ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/drug therapy ; Retrospective Studies ; Treatment Outcome ; United States/epidemiology
SCR Disease Name :
COVID-19
SCR Protocol :
COVID-19 drug treatment
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients.
Autorzy :
Pan W; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Zhang J; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Wang M; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Ye J; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Xu Y; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Shen B; Department of Medical Affairs (B.S., H.H.), Renmin Hospital of Wuhan University, China.
He H; Department of Medical Affairs (B.S., H.H.), Renmin Hospital of Wuhan University, China.
Wang Z; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Ye D; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Zhao M; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Luo Z; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Liu M; Medical Quality Management Office (Mingxiao Liu), Renmin Hospital of Wuhan University, China.
Zhang P; Department of Clinical Laboratory (P.Z., J.G.), Renmin Hospital of Wuhan University, China.
Gu J; Department of Clinical Laboratory (P.Z., J.G.), Renmin Hospital of Wuhan University, China.
Liu M; Department of Emergency (Menglin Liu), Renmin Hospital of Wuhan University, China.
Li D; Department of Pediatrics (D.L.), Renmin Hospital of Wuhan University, China.
Liu J; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Wan J; From the Department of Cardiology (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.), Renmin Hospital of Wuhan University, China.; Cardiovascular Research Institute, Wuhan University, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).; Hubei Key Laboratory of Cardiology, Wuhan, China (W.P., J.Z., M.W., J.Y., Y.X., Z.W., D.Y., M.Z., Z.L., J.L., J.W.).
Pokaż więcej
Źródło :
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2020 Sep; Vol. 76 (3), pp. 732-741. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists*/administration & dosage
Angiotensin Receptor Antagonists*/adverse effects
Angiotensin-Converting Enzyme Inhibitors*/administration & dosage
Angiotensin-Converting Enzyme Inhibitors*/adverse effects
Coronavirus Infections*/diagnosis
Coronavirus Infections*/mortality
Coronavirus Infections*/physiopathology
Essential Hypertension*/diagnosis
Essential Hypertension*/drug therapy
Essential Hypertension*/epidemiology
Pandemics*
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/mortality
Pneumonia, Viral*/physiopathology
Betacoronavirus ; China/epidemiology ; Comorbidity ; Female ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Prognosis ; Renin-Angiotensin System/drug effects ; Retrospective Studies ; Risk Assessment
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
Autorzy :
Son M; From the Department of Biomedical Science and Engineering (M.S., S.Y.), Gwangju Institute of Science and Technology, Republic of Korea.
Seo J; Department of Internal Medicine, Armed Forces Goyang Hospital, Goyang-si, Republic of Korea (J.S.).
Yang S; From the Department of Biomedical Science and Engineering (M.S., S.Y.), Gwangju Institute of Science and Technology, Republic of Korea.; School of Mechanical Engineering (S.Y.), Gwangju Institute of Science and Technology, Republic of Korea.
Pokaż więcej
Źródło :
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2020 Sep; Vol. 76 (3), pp. 742-749. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists*/administration & dosage
Angiotensin Receptor Antagonists*/adverse effects
Angiotensin-Converting Enzyme Inhibitors*/administration & dosage
Angiotensin-Converting Enzyme Inhibitors*/adverse effects
Coronavirus Infections*/diagnosis
Coronavirus Infections*/epidemiology
Coronavirus Infections*/physiopathology
Hypertension*/diagnosis
Hypertension*/drug therapy
Hypertension*/epidemiology
Pandemics*
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/physiopathology
Betacoronavirus ; Case-Control Studies ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Renin-Angiotensin System/drug effects ; Republic of Korea ; Retrospective Studies ; Risk Assessment ; Severity of Illness Index
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.
Autorzy :
Sriram K; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.
Insel PA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Department of Medicine, University of California San Diego, La Jolla, California, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Aug; Vol. 108 (2), pp. 236-241. Date of Electronic Publication: 2020 May 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info :
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin. Pharmacol. Ther. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists/*adverse effects
Angiotensin-Converting Enzyme Inhibitors/*adverse effects
Coronavirus Infections/*etiology
Peptidyl-Dipeptidase A/*metabolism
Pneumonia, Viral/*etiology
Angiotensin Receptor Antagonists/administration & dosage ; Angiotensin Receptor Antagonists/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Animals ; Coronavirus Infections/drug therapy ; Dose-Response Relationship, Drug ; Humans ; Pandemics ; Peptidyl-Dipeptidase A/blood ; Peptidyl-Dipeptidase A/urine ; Pneumonia, Viral/drug therapy
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial.
Autorzy :
Cui H; Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wu F; Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Fan Z; Department of Gastroenterology and Hepatology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Cheng X; Department of Gastroenterology and Hepatology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Cheng J; Department of Gastroenterology and Hepatology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. Electronic address: .
Fan M; Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: .
Pokaż więcej
Źródło :
Medicina clinica [Med Clin (Barc)] 2020 Oct 09; Vol. 155 (7), pp. 295-298. Date of Electronic Publication: 2020 Jun 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE
MeSH Terms :
Betacoronavirus*
Angiotensin-Converting Enzyme Inhibitors/*adverse effects
Coronavirus Infections/*etiology
Hypertension/*drug therapy
Pneumonia, Viral/*etiology
Adult ; Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Case-Control Studies ; China ; Coronavirus Infections/diagnosis ; Coronavirus Infections/therapy ; Cough/chemically induced ; Cough/virology ; Female ; Humans ; Hypertension/complications ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/therapy ; Prognosis ; Retrospective Studies ; Severity of Illness Index
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity.
Autorzy :
Otto CM; Division of Cardiology, University of Washington, Seattle, WA 98195, USA .
Pokaż więcej
Źródło :
Heart (British Cardiac Society) [Heart] 2020 Oct; Vol. 106 (19), pp. 1451-1453.
Typ publikacji :
Journal Article; Comment
Journal Info :
Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Print Cited Medium: Internet ISSN: 1468-201X (Electronic) Linking ISSN: 13556037 NLM ISO Abbreviation: Heart Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors*
Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Aldosterone ; Angiotensins ; Betacoronavirus ; Cohort Studies ; Disease Susceptibility ; Humans ; Renin
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
COVID-19: A Concern for Cardiovascular Disease Patients.
Autorzy :
Sharma S; Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Sector -12, Chandigarh, 160012, India. .
Pokaż więcej
Źródło :
Cardiovascular toxicology [Cardiovasc Toxicol] 2020 Oct; Vol. 20 (5), pp. 443-447. Date of Electronic Publication: 2020 Jul 29.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Humana Press Country of Publication: United States NLM ID: 101135818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0259 (Electronic) Linking ISSN: 15307905 NLM ISO Abbreviation: Cardiovasc. Toxicol. Subsets: MEDLINE
MeSH Terms :
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Betacoronavirus/*pathogenicity
Cardiovascular Agents/*therapeutic use
Cardiovascular Diseases/*drug therapy
Coronavirus Infections/*virology
Peptidyl-Dipeptidase A/*metabolism
Pneumonia, Viral/*virology
Virus Internalization/*drug effects
Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Cardiovascular Agents/adverse effects ; Cardiovascular Diseases/enzymology ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/physiopathology ; Coronavirus Infections/enzymology ; Coronavirus Infections/mortality ; Host Microbial Interactions ; Humans ; Pandemics ; Patient Safety ; Peptidyl-Dipeptidase A/genetics ; Pharmacogenomic Variants ; Pneumonia, Viral/enzymology ; Pneumonia, Viral/mortality ; Polymorphism, Genetic ; Prognosis ; Risk Assessment ; Risk Factors
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Treatment strategies for isolated systolic hypertension in elderly patients.
Autorzy :
Angeli F; Department of Medicine and Surgery, University of Insubria , Varese, Italy.; Department of Medicine and Cardiopulmonary Rehabilitation, Maugeri Care and Research Institutes, IRCCS Tradate , Varese, Italy.
Verdecchia P; Fondazione Umbra Cuore e Ipertensione-ONLUS and Division of Cardiology, Hospital S. Maria Della Misericordia , Perugia, Italy.
Masnaghetti S; Department of Medicine and Cardiopulmonary Rehabilitation, Maugeri Care and Research Institutes, IRCCS Tradate , Varese, Italy.
Vaudo G; Department of Medicine, University of Perugia , Perugia, Italy.
Reboldi G; Department of Medicine, University of Perugia , Perugia, Italy.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Oct; Vol. 21 (14), pp. 1713-1723. Date of Electronic Publication: 2020 Jun 25.
Typ publikacji :
Journal Article; Systematic Review
Journal Info :
Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists/*therapeutic use
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Antihypertensive Agents/*therapeutic use
Blood Pressure/*drug effects
Calcium Channel Blockers/*therapeutic use
Hypertension/*drug therapy
Sodium Chloride Symporter Inhibitors/*therapeutic use
Aged ; Angiotensin Receptor Antagonists/administration & dosage ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage ; Antihypertensive Agents/administration & dosage ; Calcium Channel Blockers/administration & dosage ; Diabetes Mellitus/drug therapy ; Drug Therapy, Combination ; Humans ; Sodium Chloride Symporter Inhibitors/administration & dosage
Czasopismo naukowe
Tytuł :
Observational data during the COVID-19 pandemic: opportunity with uncertainty.
Autorzy :
Straw S; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire, UK.
Witte KK; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire, UK .
Pokaż więcej
Źródło :
Heart (British Cardiac Society) [Heart] 2020 Oct; Vol. 106 (19), pp. 1461-1462. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji :
Editorial; Comment
Journal Info :
Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-201X (Electronic) Linking ISSN: 13556037 NLM ISO Abbreviation: Heart Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors*
Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Betacoronavirus ; Cohort Studies ; Humans ; Uncertainty
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Opinia redakcyjna
Tytuł :
Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19.
Autorzy :
Dabaghian F; Department of Pharmacognosy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Khanavi M; Department of Pharmacognosy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Faculty of Land and Food Systems, University of British Columbia, B.C., Canada.
Zarshenas MM; Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: .
Pokaż więcej
Źródło :
Medical hypotheses [Med Hypotheses] 2020 Oct; Vol. 143, pp. 109841. Date of Electronic Publication: 2020 May 16.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Eden Press Country of Publication: United States NLM ID: 7505668 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2777 (Electronic) Linking ISSN: 03069877 NLM ISO Abbreviation: Med Hypotheses Subsets: MEDLINE
MeSH Terms :
Pandemics*/prevention & control
Phytotherapy*
Angiotensin-Converting Enzyme Inhibitors/*pharmacology
Coronavirus Infections/*drug therapy
Phytochemicals/*pharmacology
Pneumonia, Viral/*drug therapy
Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Betacoronavirus/drug effects ; Betacoronavirus/metabolism ; Coronavirus Infections/prevention & control ; Cytokines/metabolism ; Humans ; Peptidyl-Dipeptidase A/drug effects ; Peptidyl-Dipeptidase A/metabolism ; Phytochemicals/therapeutic use ; Pneumonia, Viral/prevention & control ; Receptors, Virus/antagonists & inhibitors ; Receptors, Virus/metabolism
SCR Disease Name :
COVID-19
SCR Protocol :
COVID-19 drug treatment
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Raport
Tytuł :
A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
Autorzy :
Wang Z; Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Zhang D; Department of Nephrology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Wang S; Department of Ultrasonic Diagnosis, People's Liberation Army (PLA) 988 Hospital, Zhengzhou, Henan, China (mainland).
Jin Y; Department of Nephrology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Huan J; Department of Respiratory Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Wu Y; Department of Military Health Service Training Center, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Xia C; Department of Nephrology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Li Z; Department of Ultrasonic Diagnosis, People's Liberation Army (PLA) 546 Hospital, Malan, Xinjiang, China (mainland).
Qi X; Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Zhang D; Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Han X; Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Zhu X; Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Qu Y; Department of Military Patients Administration, General Hospital of Northern Theater Command, Shenyang, Liaoning, China (mainland).
Wang Q; Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China (mainland).
Pokaż więcej
Źródło :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2020 Sep 24; Vol. 26, pp. e926651. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
Journal Info :
Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 9609063 Publication Model: Electronic Cited Medium: Internet ISSN: 1643-3750 (Electronic) Linking ISSN: 12341010 NLM ISO Abbreviation: Med Sci Monit Subsets: MEDLINE
MeSH Terms :
Betacoronavirus*
Pandemics*
Angiotensin Receptor Antagonists/*therapeutic use
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Antihypertensive Agents/*therapeutic use
Coronavirus Infections/*complications
Hypertension/*complications
Pneumonia, Viral/*complications
Aged ; Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Antihypertensive Agents/adverse effects ; China ; Comorbidity ; Female ; Hospital Mortality ; Humans ; Hypertension/drug therapy ; Intensive Care Units/statistics & numerical data ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Peptidyl-Dipeptidase A/biosynthesis ; Peptidyl-Dipeptidase A/drug effects ; Propensity Score ; Retrospective Studies ; Survival Rate ; Treatment Outcome
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
ACE2, the Receptor that Enables Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.
Autorzy :
Gross LZF; Chemical Biology of Regulatory Mechanisms, IBioBA-CONICET-Partner Institute of the Max Planck Society, Godoy Cruz 2390, Buenos Aires, Argentina.
Sacerdoti M; Chemical Biology of Regulatory Mechanisms, IBioBA-CONICET-Partner Institute of the Max Planck Society, Godoy Cruz 2390, Buenos Aires, Argentina.
Piiper A; Internal Medicine I, Frankfurt University Hospital, Theodor-Stern-Kai 7, Frankfurt am Main, Germany.
Zeuzem S; Internal Medicine I, Frankfurt University Hospital, Theodor-Stern-Kai 7, Frankfurt am Main, Germany.
Leroux AE; Chemical Biology of Regulatory Mechanisms, IBioBA-CONICET-Partner Institute of the Max Planck Society, Godoy Cruz 2390, Buenos Aires, Argentina.
Biondi RM; Chemical Biology of Regulatory Mechanisms, IBioBA-CONICET-Partner Institute of the Max Planck Society, Godoy Cruz 2390, Buenos Aires, Argentina.; Internal Medicine I, Frankfurt University Hospital, Theodor-Stern-Kai 7, Frankfurt am Main, Germany.
Pokaż więcej
Źródło :
ChemMedChem [ChemMedChem] 2020 Sep 16; Vol. 15 (18), pp. 1682-1690. Date of Electronic Publication: 2020 Aug 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info :
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE
MeSH Terms :
Angiotensin-Converting Enzyme Inhibitors/*metabolism
Betacoronavirus/*chemistry
Peptidyl-Dipeptidase A/*metabolism
Receptors, Virus/*metabolism
Spike Glycoprotein, Coronavirus/*metabolism
Allosteric Regulation ; Angiotensin-Converting Enzyme Inhibitors/chemistry ; Catalytic Domain ; Humans ; Peptidyl-Dipeptidase A/chemistry ; Protein Binding ; Protein Domains ; Receptors, Virus/antagonists & inhibitors ; Receptors, Virus/chemistry ; Spike Glycoprotein, Coronavirus/chemistry
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Differential Effects of Combination of Renin-Angiotensin-Aldosterone System Inhibitors on Central Aortic Blood Pressure: A Cross-Sectional Observational Study in Hypertensive Outpatients.
Autorzy :
Pradhan A; Department of Cardiology, King George Medical University, Shah Mina Road, Chowk, 226003, Lucknow, Uttar Pradesh, India.
Vishwakarma P; Department of Cardiology, King George Medical University, Shah Mina Road, Chowk, 226003, Lucknow, Uttar Pradesh, India.
Bhandari M; Department of Cardiology, King George Medical University, Shah Mina Road, Chowk, 226003, Lucknow, Uttar Pradesh, India.
Sethi R; Department of Cardiology, King George Medical University, Shah Mina Road, Chowk, 226003, Lucknow, Uttar Pradesh, India.
Narain VS; Department of Cardiology, King George Medical University, Shah Mina Road, Chowk, 226003, Lucknow, Uttar Pradesh, India.
Pokaż więcej
Źródło :
Cardiovascular therapeutics [Cardiovasc Ther] 2020 Sep 07; Vol. 2020, pp. 4349612. Date of Electronic Publication: 2020 Sep 07 (Print Publication: 2020).
Typ publikacji :
Comparative Study; Journal Article; Observational Study
Journal Info :
Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: eCollection Cited Medium: Internet ISSN: 1755-5922 (Electronic) Linking ISSN: 17555914 NLM ISO Abbreviation: Cardiovasc Ther Subsets: MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists/*therapeutic use
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Antihypertensive Agents/*therapeutic use
Arterial Pressure/*drug effects
Hypertension/*drug therapy
Renin-Angiotensin System/*drug effects
Adult ; Aged ; Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Antihypertensive Agents/adverse effects ; Cross-Sectional Studies ; Drug Therapy, Combination ; Female ; Humans ; Hypertension/diagnosis ; Hypertension/physiopathology ; India ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.
Autorzy :
Muchtaridi M; Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl Raya 21.5, Bandung-Sumedang 45363, Indonesia.
Fauzi M; Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl Raya 21.5, Bandung-Sumedang 45363, Indonesia.
Khairul Ikram NK; Institute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.; Centre for Research in Biotechnology for Agriculture (CEBAR), Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Mohd Gazzali A; Department of Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, Malaysia.
Wahab HA; Pharmaceutical Design and Simulation Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, Malaysia.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2020 Sep 01; Vol. 25 (17). Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :
Journal Article; Meta-Analysis; Review
Journal Info :
Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE
MeSH Terms :
Angiotensin-Converting Enzyme Inhibitors/*pharmacology
Antiviral Agents/*pharmacology
Betacoronavirus/*drug effects
Betacoronavirus/*physiology
Biological Products/*pharmacology
Coronavirus Infections/*virology
Flavonoids/*pharmacology
Pneumonia, Viral/*virology
Angiotensin-Converting Enzyme Inhibitors/chemistry ; Antiviral Agents/chemistry ; Biological Products/chemistry ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Disease Susceptibility ; Flavonoids/chemistry ; Humans ; Life Cycle Stages ; Models, Molecular ; Pandemics ; Peptidyl-Dipeptidase A/chemistry ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Population Surveillance ; Structure-Activity Relationship
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
The role of ACEIs/ARBs in COVID-19: Friend or foe?
Autorzy :
Zhou Z; Department of Hypertension and Vascular Disease, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Qiu Y; Department of Hypertension and Vascular Disease, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Tao J; Department of Hypertension and Vascular Disease, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address: .
Pokaż więcej
Źródło :
Medical hypotheses [Med Hypotheses] 2020 Sep; Vol. 142, pp. 109810. Date of Electronic Publication: 2020 May 05.
Typ publikacji :
Letter
Journal Info :
Publisher: Eden Press Country of Publication: United States NLM ID: 7505668 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2777 (Electronic) Linking ISSN: 03069877 NLM ISO Abbreviation: Med Hypotheses Subsets: MEDLINE
MeSH Terms :
Betacoronavirus*
Angiotensin Receptor Antagonists/*pharmacology
Angiotensin-Converting Enzyme Inhibitors/*pharmacology
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Coronavirus Infections/enzymology ; Coronavirus Infections/etiology ; Disease Susceptibility ; Humans ; Models, Biological ; Pandemics ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/enzymology ; Pneumonia, Viral/etiology ; Research Design
SCR Disease Name :
COVID-19
SCR Protocol :
COVID-19 drug treatment
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Opinia redakcyjna
Tytuł :
Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
Autorzy :
Greco A; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Buccheri S; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
D'Arrigo P; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Calderone D; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Agnello F; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Monte M; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Milluzzo RP; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Franchina AG; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Ingala S; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Capodanno D; Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria 'Policlinico-San Marco', University of Catania, Catania, Italy.
Pokaż więcej
Źródło :
European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2020 Sep 01; Vol. 6 (5), pp. 335-337.
Typ publikacji :
Letter; Meta-Analysis; Systematic Review
Journal Info :
Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists/*therapeutic use
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Antiviral Agents/*therapeutic use
Betacoronavirus/*drug effects
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
Renin-Angiotensin System/*drug effects
Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Antiviral Agents/adverse effects ; Betacoronavirus/pathogenicity ; Coronavirus Infections/metabolism ; Coronavirus Infections/mortality ; Coronavirus Infections/virology ; Host-Pathogen Interactions ; Humans ; Pandemics ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/mortality ; Pneumonia, Viral/virology ; Risk Factors ; Treatment Outcome
SCR Disease Name :
COVID-19
SCR Protocol :
COVID-19 drug treatment
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Raport
Tytuł :
Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
Autorzy :
Zemlin AE; Department of Pathology, Chemical Pathology Division, National Health Laboratory Service (NHLS) and University of Stellenbosch, Tygerberg Hospital, Cape Town, South Africa.
Wiese OJ; Department of Pathology, Chemical Pathology Division, National Health Laboratory Service (NHLS) and University of Stellenbosch, Tygerberg Hospital, Cape Town, South Africa.
Pokaż więcej
Źródło :
Annals of clinical biochemistry [Ann Clin Biochem] 2020 Sep; Vol. 57 (5), pp. 339-350. Date of Electronic Publication: 2020 Jun 02.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Sage Country of Publication: England NLM ID: 0324055 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1001 (Electronic) Linking ISSN: 00045632 NLM ISO Abbreviation: Ann Clin Biochem Subsets: MEDLINE
MeSH Terms :
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Betacoronavirus/*metabolism
Coronavirus Infections/*drug therapy
Coronavirus Infections/*metabolism
Peptidyl-Dipeptidase A/*metabolism
Pneumonia, Viral/*drug therapy
Pneumonia, Viral/*metabolism
Renin-Angiotensin System/*physiology
Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Animals ; Betacoronavirus/drug effects ; Betacoronavirus/immunology ; Coronavirus Infections/immunology ; Humans ; Pandemics ; Peptidyl-Dipeptidase A/immunology ; Pneumonia, Viral/immunology ; Renin-Angiotensin System/drug effects
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors.
Autorzy :
Vistisen ST; From the Department of Clinical Medicine, Aarhus University, Aarhus (STV), Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark (JB), Department of Anaesthesiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands (TWLS) and Department of Biomedicine, Aarhus University, Aarhus, Denmark (US).
Bodilsen J
Scheeren TWL
Simonsen U
Pokaż więcej
Źródło :
European journal of anaesthesiology [Eur J Anaesthesiol] 2020 Sep; Vol. 37 (9), pp. 739-742.
Typ publikacji :
Editorial
Journal Info :
Publisher: Lippincott Williams & Wilkins, 2009- Country of Publication: England NLM ID: 8411711 Publication Model: Print Cited Medium: Internet ISSN: 1365-2346 (Electronic) Linking ISSN: 02650215 NLM ISO Abbreviation: Eur J Anaesthesiol Subsets: MEDLINE
MeSH Terms :
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
Renin-Angiotensin System/*drug effects
Angiotensin II Type 1 Receptor Blockers/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Antihypertensive Agents/therapeutic use ; Coronavirus Infections/complications ; Humans ; Observational Studies as Topic ; Pandemics ; Pneumonia, Viral/complications ; Prognosis ; Risk Assessment
SCR Disease Name :
COVID-19
Opinia redakcyjna
Tytuł :
Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia.
Autorzy :
Seid E; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Engidawork E; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Alebachew M; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Mekonnen D; Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Berha AB; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Aug 28; Vol. 15 (8), pp. e0237781. Date of Electronic Publication: 2020 Aug 28 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
MeSH Terms :
Adrenergic beta-Antagonists/*adverse effects
Angiotensin-Converting Enzyme Inhibitors/*adverse effects
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Heart Failure/*drug therapy
Medication Adherence/*statistics & numerical data
Patient Satisfaction/*statistics & numerical data
Adolescent ; Adrenergic beta-Antagonists/pharmacokinetics ; Adult ; Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics ; Cross-Sectional Studies ; Drug Interactions ; Drug-Related Side Effects and Adverse Reactions/etiology ; Drug-Related Side Effects and Adverse Reactions/psychology ; Ethiopia/epidemiology ; Female ; Follow-Up Studies ; Humans ; Male ; Medication Adherence/psychology ; Middle Aged ; Outpatient Clinics, Hospital/statistics & numerical data ; Prevalence ; Prospective Studies ; Quality of Life ; Surveys and Questionnaires/statistics & numerical data ; Tertiary Care Centers/statistics & numerical data ; Young Adult
Czasopismo naukowe
Tytuł :
COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.
Autorzy :
Kussmaul WG 3rd; Media, Pennsylvania (W.G.K.).
Pokaż więcej
Źródło :
Annals of internal medicine [Ann Intern Med] 2020 Aug 04; Vol. 173 (3), pp. 237-238. Date of Electronic Publication: 2020 May 15.
Typ publikacji :
Journal Article; Comment
Journal Info :
Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann. Intern. Med. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors*
Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Angiotensins ; Betacoronavirus ; Humans
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies